The Syneos Health Podcast
152 Avsnitt
-
Payer Power, Part 3
Publicerades: 2020-07-15 -
CORONAVIRUS SPECIAL EDITION, Episode 12: COVID-19 and Children
Publicerades: 2020-06-19 -
CORONAVIRUS SPECIAL EDITION, Episode 11: Rare Disease Clinical Trials and COVID-19
Publicerades: 2020-06-02 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Yelp Ratings for Clinical Trials
Publicerades: 2020-05-27 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
Publicerades: 2020-05-15 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Real World Data for Clinical Innovation
Publicerades: 2020-05-08 -
CORONAVIRUS SPECIAL EDITION, Episode 10: Ventilating the COVID-19 Patient
Publicerades: 2020-05-05 -
CORONAVIRUS SPECIAL EDITION, Episode 9: Telemedicine in the Age of COVID-19
Publicerades: 2020-04-23 -
CORONAVIRUS SPECIAL EDITION, Episode 8: Payers and COVID-19
Publicerades: 2020-04-16 -
CORONAVIRUS SPECIAL EDITION, Episode 7: Continuity in Clinical Trials
Publicerades: 2020-04-02 -
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Publicerades: 2020-03-30 -
CORONAVIRUS SPECIAL EDITION, Episode 5: Surviving the Ventilator Shortage
Publicerades: 2020-03-24 -
CORONAVIRUS SPECIAL EDITION, Episode 4: Clinical Trials Through Pandemics
Publicerades: 2020-03-24 -
CORONAVIRUS SPECIAL EDITION, Episode 3: Virtual Clinical Trials
Publicerades: 2020-03-20 -
CORONAVIRUS SPECIAL EDITION, Episode 2: The Clinical Experience
Publicerades: 2020-03-17 -
CORONAVIRUS SPECIAL EDITION, Episode 1: The Personal Experience
Publicerades: 2020-03-13 -
Recruiting Patients for Clinical Trials
Publicerades: 2020-03-06 -
Medical Affairs Series, Part Six: Commercial Plus Medical Affairs
Publicerades: 2020-02-19 -
2020 Health Trends: Box Store Healthcare
Publicerades: 2020-02-05 -
Denials, Delays and Deep Discounts in Pharmaceutical Launch
Publicerades: 2020-01-24
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
